Valuation
OZPHOzon Pharmaceuticals
StockMoscow ExchangeRussiaHealth care
+0.3% today · −7.8% over a year
8/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 84% of the instruments we score
Stability: among the best of its peers. Dividend yield 2.77%.
Ratios vs sector
Medians of Health care companies worldwide (too few in the region).
| Metric | OZPH | Sector median | vs median |
|---|---|---|---|
| P/E | — | 28.3 · n=183 | — |
| P/B | — | 3.7 · n=351 | — |
| P/S | — | 4.1 · n=339 | — |
| EV/EBIT | — | 24.6 · n=173 | — |
| Free-cash-flow yield | — | 1.6% · n=328 | — |
| Dividend yield | 2.77% | 0.00% · n=469 | — |
| Return on equity | — | −1.2% · n=361 | — |
| Return on invested capital | — | 3.1% · n=326 | — |
| Gross margin | — | 64.2% · n=243 | — |
| Net debt / EBITDA | — | 1.30 · n=174 | — |
Value factor: 41 of 100 within the peer group. Full score breakdown →
Sector peers
The largest companies of the same sector and region.
| LLYEli Lilly & Co | 46.2 | 31.6 | — | 1.5% | 0.6% | 6/10 |
|---|---|---|---|---|---|---|
| JNJJohnson & Johnson | 41.3 | 8.2 | — | 3.1% | 1.9% | 8/10 |
| ABBVAbbVie | 50.0 | — | 27.6 | 3.7% | 2.9% | 6/10 |
| MRKMerck | 147.5 | 8.1 | — | 4.1% | 2.3% | 8/10 |
| UNHUnitedHealth | 22.2 | 3.4 | 16.9 | 6.5% | 2.3% | 10/10 |
| NVSNovartis AG | 22.2 | 6.7 | 18.6 | 5.7% | 2.4% | 10/10 |
| NOVNNovartis AG | 22.2 | 6.7 | 18.6 | 5.7% | 2.8% | 10/10 |
| AZNAstraZeneca plc | 28.3 | 5.9 | 22.8 | 4.1% | 1.7% | 6/10 |
| AZNAstraZeneca PLC | 28.3 | 5.9 | 22.8 | 4.1% | 1.2% | 6/10 |
| TMOThermo Fisher Scientific | 36.4 | 4.7 | 34.5 | 3.0% | 0.3% | 9/10 |
ratios computed by AI-Stock Invest from public filings and end-of-day prices
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.